322
On 10/12/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 503. The active ingredient is Recombinant human hepatitis C monoclonal antibody against C4 region of E1 for prevention of recurrent hepatitis C virus induced liver disease in liver transplant recipients.